 |
PDBsum entry 1i16
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Cytokine
|
 |
|
Title:
|
 |
Structure of interleukin 16: implications for function, nmr, 20 structures
|
|
Structure:
|
 |
Interleukin 16. Chain: a. Synonym: lcf. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Cell_line: bl21. Cell: cd8+ t cells. Cellular_location: extracellular. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
NMR struc:
|
 |
20 models
|
 |
|
Authors:
|
 |
P.Muehlhahn,M.Zweckstetter,J.Georgescu,C.Ciosto,C.Renner, M.Lanzendoerfer,K.Lang,D.Ambrosius,M.Baier,R.Kurth,T.A.Holak
|
Key ref:
|
 |
P.Mühlhahn
et al.
(1998).
Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site.
Nat Struct Biol,
5,
682-686.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-May-98
|
Release date:
|
25-May-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q14005
(IL16_HUMAN) -
Pro-interleukin-16 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1332 a.a.
130 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
5:682-686
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site.
|
|
P.Mühlhahn,
M.Zweckstetter,
J.Georgescu,
C.Ciosto,
C.Renner,
M.Lanzendörfer,
K.Lang,
D.Ambrosius,
M.Baier,
R.Kurth,
T.A.Holak.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of a folded core of IL-16 is similar to that of intracellular
protein modules called PDZ domains. IL-16 is thus the first extracellular
protein found to have a PDZ-like fold. However, it does not exhibit normal
peptide binding properties of PDZ domains. This is due to alterations of the
structure at the 'PDZ-like binding site' of IL-16 (the GLGF cleft): the GLGF
cleft of IL-16 is much smaller than those of PDZ-domains and is additionally
blocked with a tryptophan side chain at its center. Our experiments indicate
also that IL-16 nonspecifically aggregates in solution; but formation of a
homo-tetrameric protein is not required, in contrast to previous suggestions,
for its chemo-attractant activity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. a, Steady-state heteronuclear ^15N{^1 H}-NOE for the
backbone amides of IL-16. Residues for which no results are
shown correspond either to prolines or to residues for which the
relaxation data could not be extracted. b, ^1H-^15N HSQC
spectrum of human IL-16^1−130 at pH 7.4, circles identify
residues for which cross peaks were observed only at pH 6.5.
|
 |
Figure 4.
Figure 4. a, Comparison of the overall topologies of IL-16 and
Dlg_A. b, Conformation of the Gly-Leu-Gly-Phe cleft in human
IL-16 (red).The side chain of Trp 99 is marked in green.
Conformation of the side chain atoms for residues 41−46 are
also shown. Conformation of the GLGF site in human Dlg_A is in
blue^22. The side chain of Ala 529 is shown in green (this
residue corresponds to Trp 99 in IL-16).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(1998,
5,
682-686)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
F.Croq,
J.Vizioli,
M.Tuzova,
M.Tahtouh,
P.E.Sautiere,
C.Van Camp,
M.Salzet,
W.W.Cruikshank,
J.Pestel,
and
C.Lefebvre
(2010).
A homologous form of human interleukin 16 is implicated in microglia recruitment following nervous system injury in leech Hirudo medicinalis.
|
| |
Glia,
58,
1649-1662.
|
 |
|
|
|
|
 |
W.G.Glass,
R.T.Sarisky,
and
A.M.Vecchio
(2006).
Not-so-sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases.
|
| |
J Interferon Cytokine Res,
26,
511-520.
|
 |
|
|
|
|
 |
F.F.Little,
and
W.W.Cruikshank
(2004).
Interleukin-16 and peptide derivatives as immunomodulatory therapy in allergic lung disease.
|
| |
Expert Opin Biol Ther,
4,
837-846.
|
 |
|
|
|
|
 |
E.L.Lynch,
F.F.Little,
K.C.Wilson,
D.M.Center,
and
W.W.Cruikshank
(2003).
Immunomodulatory cytokines in asthmatic inflammation.
|
| |
Cytokine Growth Factor Rev,
14,
489-502.
|
 |
|
|
|
|
 |
M.L.Yeung,
T.S.Tam,
A.C.Tsang,
and
K.M.Yao
(2003).
Proteolytic cleavage of PDZD2 generates a secreted peptide containing two PDZ domains.
|
| |
EMBO Rep,
4,
412-418.
|
 |
|
|
|
|
 |
N.Bannert,
K.Vollhardt,
B.Asomuddinov,
M.Haag,
H.König,
S.Norley,
and
R.Kurth
(2003).
PDZ Domain-mediated interaction of interleukin-16 precursor proteins with myosin phosphatase targeting subunits.
|
| |
J Biol Chem,
278,
42190-42199.
|
 |
|
|
|
|
 |
T.Yamanaka,
Y.Horikoshi,
Y.Sugiyama,
C.Ishiyama,
A.Suzuki,
T.Hirose,
A.Iwamatsu,
A.Shinohara,
and
S.Ohno
(2003).
Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity.
|
| |
Curr Biol,
13,
734-743.
|
 |
|
|
|
|
 |
H.Kornfeld,
and
W.W.Cruikshank
(2001).
Prospects for IL-16 in the treatment of AIDS.
|
| |
Expert Opin Biol Ther,
1,
425-432.
|
 |
|
|
|
|
 |
K.Ebnet,
A.Suzuki,
Y.Horikoshi,
T.Hirose,
M.K.Meyer Zu Brickwedde,
S.Ohno,
and
D.Vestweber
(2001).
The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM).
|
| |
EMBO J,
20,
3738-3748.
|
 |
|
|
|
|
 |
R.Stoll,
C.Renner,
M.Zweckstetter,
M.Brüggert,
D.Ambrosius,
S.Palme,
R.A.Engh,
M.Golob,
I.Breibach,
R.Buettner,
W.Voelter,
T.A.Holak,
and
A.K.Bosserhoff
(2001).
The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.
|
| |
EMBO J,
20,
340-349.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.M.Leutenegger,
F.S.Boretti,
C.N.Mislin,
J.N.Flynn,
M.Schroff,
A.Habel,
C.Junghans,
S.A.Koenig-Merediz,
B.Sigrist,
A.Aubert,
N.C.Pedersen,
B.Wittig,
and
H.Lutz
(2000).
Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.
|
| |
J Virol,
74,
10447-10457.
|
 |
|
|
|
|
 |
C.M.Leutenegger,
J.B.Huder,
C.N.Mislin,
F.Lahrtz,
R.Hofmann-Lehmann,
N.C.Pedersen,
and
H.Lutz
(2000).
Molecular characterization of feline interleukin 16: chemotactic activity and effect on feline immunodeficiency virus infection and/or replication.
|
| |
AIDS Res Hum Retroviruses,
16,
569-575.
|
 |
|
|
|
|
 |
G.Kozlov,
K.Gehring,
and
I.Ekiel
(2000).
Solution structure of the PDZ2 domain from human phosphatase hPTP1E and its interactions with C-terminal peptides from the Fas receptor.
|
| |
Biochemistry,
39,
2572-2580.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |